Druggable Targets in Cytokine Release Syndromes.

Luri-Rey, Carlos; Eguren-Santamaria, Iñaki; Matos, Ignacio; Berraondo, Pedro; Melero, Ignacio

Luri-Rey, Carlos; Eguren-Santamaria, Iñaki; Matos, Ignacio; Berraondo, Pedro; Melero, Ignacio.

Affiliation

Luri-Rey C; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.
Eguren-Santamaria I; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
Matos I; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.
Berraondo P; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
Melero I; Department of Oncology, Clinica Universidad de Navarra, Madrid, Spain.

Clin Cancer Res ; 29(21): 4320-4322, 2023 11 01.

Article in En | MEDLINE | ID: mdl-37656058

Subject(s)

Antibodies, Bispecific; Cytokine Release Syndrome; Humans; Cytokine Release Syndrome/drug therapy; Cytokine Release Syndrome/etiology; Cytokine Release Syndrome/prevention & control; T-Lymphocytes; Cytokines; Antigens, CD19

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Cytokine Release Syndrome Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Spain Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google